Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK001 [Phase 1]

View source ↗

Summary

The entry notes completion of a Phase 1 study evaluating AK001 (lirentelimab) for atopy, including assessments of safety, tolerability, pharmacokinetics, and ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopy

Drugs mentioned

• AK001 (lirentelimab)

Snippet

Sponsor: Allakos Inc. | Conditions: Atopy | Phase 1 | Status: COMPLETED